Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar francisdeep1 (< 20) Submitted: 10/31/2011 1:47:15 AM : Outperform Start Price: $2.67 BPAX Score: -84.76

run before fda review nov.14,2011

Report this Post Reply

Featured Broker Partners


Advertisement